NCT04309305 (RE-Assist) is a Phase 1 clinical trial of EksoGT™, Ekso Bionics, Berkley, CA, USA in CVA, sponsored by Kessler Foundation.

Who is sponsoring NCT04309305?

NCT04309305 is sponsored by Kessler Foundation.

What drugs are being tested in NCT04309305?

Interventions in NCT04309305: EksoGT™, Ekso Bionics, Berkley, CA, USA, Standard of Care, No Intervention.

What condition does NCT04309305 study?

NCT04309305 studies CVA, Gait, Hemiplegic.

Is NCT04309305 still recruiting?

NCT04309305 is currently enrolling by invitation. Last updated 6 April 2025.

Last reviewed 2025-04-06 · How we verify

NCT04309305: RE-Assist

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic Exoskeleton Assisted Gait Post Stroke

ENROLLING BY INVITATION Phase 1 Last updated 6 April 2025

What this trial tests

Phase 1 trial testing EksoGT™, Ekso Bionics, Berkley, CA, USA in CVA in 75 participants. Enrolling by invitation.

Timeline

30 January 2020

Primary endpoint
1 May 2026

1 September 2026

Quick facts

Lead sponsor	Kessler Foundation
Phase	Phase 1
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	75
Start date	30 January 2020
Primary completion	1 May 2026
Estimated completion	1 September 2026
Sites	1 location across United States

Drugs / interventions tested

EksoGT™, Ekso Bionics, Berkley, CA, USA
Standard of Care
No Intervention

Conditions studied

CVA — all drugs for CVA →
Gait, Hemiplegic — all drugs for Gait, Hemiplegic →

Sponsor

Kessler Foundation

Who can join

Adults 21 to 80, any sex, with CVA or Gait, Hemiplegic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for CVA

Currently open trials in the same condition.

NCT06498011 — COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO) · NA · recruiting

Other Kessler Foundation trials

Trials by the same sponsor.

NCT07168941 — Evaluation and Refinement of KF-STRIDE Into the Interview! · NA · not yet recruiting
NCT07159100 — tDCS for Cancer-Related Fatigue and Weakness · EARLY_PHASE1 · not yet recruiting
NCT06886152 — Spinal Stimulation and Gait Training to Improve Mobility in TBI · NA · not yet recruiting
NCT07073313 — Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI · not yet recruiting
NCT06923293 — Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04309305 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kessler Foundation
Last refreshed: 6 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04309305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing